1. Effect of tofacitinib withdrawal and re‐treatment on patient‐reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis. (7th September 2016) Authors: Griffiths, C.E.M.; Vender, R.; Sofen, H.; Kircik, L.; Tan, H.; Rottinghaus, S.T.; Bachinsky, M.; Mallbris, L.; Mamolo, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 2(2017) Page Start: 323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trials. (30th March 2018) Authors: Gottlieb, A.B.; Gordon, K.; Hsu, S.; Elewski, B.; Eichenfield, L.F.; Kircik, L.; Rastogi, S.; Pillai, R.; Israel, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 8(2018) Page Start: 1305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Quality of life and patient‐perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed‐dose combination Cal/BD foam: A post‐hoc analysis of PSO‐LONG. (21st October 2021) Authors: Jalili, A.; Calzavara‐Pinton, P.; Kircik, L.; Lons‐Danic, D.; Pink, A.; Tyring, S.; de la Cueva, P.; Gooderham, M.; Segaert, S.; Nyholm, N.; Thoning, H.; Petersen, B.; Thaçi, D. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 1(2022) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Secukinumab improves the signs and symptoms of moderate‐to‐severe plaque psoriasis in subjects with involvement of hands and/or feet: subanalysis of a randomized, double‐blind, placebo‐controlled, phase 2 dose‐ranging study. (13th December 2013) Authors: Sigurgeirsson, B.; Kircik, L.; Nemoto, O.; Mikazans, I.; Haemmerle, S.; Thurston, H.J.; Papavassilis, C.; Richards, H.B. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 28:Number 8(2014:Aug.) Page Start: 1127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*. (1st March 2021) Authors: Wollenberg, A.; Blauvelt, A.; Guttman‐Yassky, E.; Worm, M.; Lynde, C.; Lacour, J.‐P.; Spelman, L.; Katoh, N.; Saeki, H.; Poulin, Y.; Lesiak, A.; Kircik, L.; Cho, S.H.; Herranz, P.; Cork, M.J.; Peris, K.; Steffensen, L.A.; Bang, B.; Kuznetsova, A.; Jensen, T.N. Journal: British journal of dermatology Issue: Volume 184:Number 3(2021) Page Start: 437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2). (1st March 2021) Authors: Wollenberg, A.; Blauvelt, A.; Guttman‐Yassky, E.; Worm, M.; Lynde, C.; Lacour, J.‐P.; Spelman, L.; Katoh, N.; Saeki, H.; Poulin, Y.; Lesiak, A.; Kircik, L.; Cho, S.H.; Herranz, P.; Cork, M.J.; Peris, K.; Steffensen, L.A.; Bang, B.; Kuznetsova, A.; Jensen, T.N. Journal: British journal of dermatology Issue: Volume 184:Number 3(2021) Page Start: 437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2). (30th December 2020) Authors: Wollenberg, A.; Blauvelt, A.; Guttman‐Yassky, E.; Worm, M.; Lynde, C.; Lacour, J.‐P.; Spelman, L.; Katoh, N.; Saeki, H.; Poulin, Y.; Lesiak, A.; Kircik, L.; Cho, S.H.; Herranz, P.; Cork, M.J.; Peris, K.; Steffensen, L.A.; Bang, B.; Kuznetsova, A.; Jensen, T.N. Journal: British journal of dermatology Issue: Volume 184:Number 3(2021) Page Start: 437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗